Eversana establishes data and analytics offering, appoints Brigham Hyde president

Eversana has established a data and analytics business and appointed Brigham Hyde as president of.

Five things for pharma marketers to know: Friday, April 24, 2020

Data from a COVID-19 trial of Gilead’s remdesivir showed no benefit. The antiviral drug did.

Five things for pharma marketers to know: Thursday, April 23, 2020

The government is planning to assist hospitals and doctors who provide care for uninsured patients.

IPG Q1 results cannot be indicative of what’s to come, warns CEO

IPG’s head has warned that Q1 results “cannot be indicative of the remainder of the.

Weekly HCP surveys reveal concerns about patient care, provider anxiety

As the COVID-19 pandemic keeps the industry in a state of flux, Fingerpaint has started.

Study: Physicians changing prescribing habits, embracing telemedicine during COVID-19 crisis

To better understand how physicians are responding to the tectonic changes prompted by the coronavirus.

Wego Health event outlines potential for stronger patient/pharma pairings in rare and chronic spaces

Amid the COVID-19 pandemic, patient community leader Wego Health held a Zoom conference with chronic.

Five things for pharma marketers to know: Friday, April 17, 2020

Gilead’s remdesivir has shown early promise treating COVID-19 patients. Patients involved in the clinical trial have.

5 “Little” Details That Affect Patient Retention/Conversions

In the business of healthcare, the level of care you provide will always be the.

Direct Mail Is NOT Dead: 5 Reasons It Still Works for Healthcare

Direct mail is not dead. At a time when email inboxes are overflowing, how else.